CytomX Therapeutics

CTMXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$640.624 M

$2.94 +6.52%

Close of 22 Sept 2026

Revenue

$76.2M

#2598 by revenue

Earnings

-$17.4M

Loss-making

Shares outstanding

217,899,284

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#190Shattuck LabsSTTK$652.4M
#191Monopar TherapeuticsMNPR$648.6M
#192CytomX TherapeuticsCTMX$640.6M
#193Phathom PharmaceuticalsPHAT$627.8M
#194Aquestive TherapeuticsAQST$621.3M

What if CytomX Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$138,752.04

Per share 47,195× higher

Bitcoin $1.74T

$7,992.94

Per share 2,719× higher

Nvidia $5.52T

$25,313.38

Per share 8,610× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for CytomX Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.